Journal of Leukemia & Lymphoma 2019;28(12):713-715

doi:10.3760/cma.j.issn.1009-9921.2019.12.003

Diagnosis and treatment progress of follicular lymphoma

Bing XU 1 ; Zhijuan LIN

Affiliations

+expand

Keywords

Lymphoma, follicular; Genetics; Prognosis; Molecular targeted therapy

Country

China

Language

Chinese

Abstract

Follicular lymphoma (FL) is the most common indolent lymphoma. With the improvement of disease awareness and the introduction of various novel drugs, the 5-year overall survival rate has been more than 90% for the majority of FL patients. However, certain subgroups of FL patients, especially patients who progressed within 24 months after starting front-line therapy, still have worse outcome. This article reviews the progress in genetics, prognostic factors and treatment options of FL that reported at the 61st American Society of Hematology Annual Meeting 2019.